Page last updated: 2024-08-24

fluorodeoxyglucose f18 and calpain

fluorodeoxyglucose f18 has been researched along with calpain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amamoto, M; Azuma, M; Hattori, S; Hayasaka, K; Hirotsune, S; Kataoka, Y; Kato, M; Kumamoto, K; Miyakawa, T; Oka, Y; Sato, M; Takao, K; Tamura, Y; Toba, S; Tominaga, K; Wanibuchi, H; Wynshaw-Boris, A; Yamada, M	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and calpain

Article	Year
Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly. Scientific reports, 2013, Volume: 3 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Administration, Oral; Animals; Blood-Brain Barrier; Calpain; Carbamates; Cell Line; Fluorodeoxyglucose F18; Glycoproteins; Humans; Lissencephaly; Male; Mice; Microtubule-Associated Proteins; Motor Activity; Nerve Growth Factor; Neurons; Positron-Emission Tomography; Receptors, GABA	2013

Article

Year

Post-natal treatment by a blood-brain-barrier permeable calpain inhibitor, SNJ1945 rescued defective function in lissencephaly.

Scientific reports, 2013, Volume: 3

Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Administration, Oral; Animals; Blood-Brain Barrier; Calpain; Carbamates; Cell Line; Fluorodeoxyglucose F18; Glycoproteins; Humans; Lissencephaly; Male; Mice; Microtubule-Associated Proteins; Motor Activity; Nerve Growth Factor; Neurons; Positron-Emission Tomography; Receptors, GABA

2013